DISCLAIMER

EXCLUSIVE LICENCE AGREEMENT WITH RUTGERS UNIVERSITY

Lipotech has signed Exclusive Licence Agreement (Patents and IP Rights) with Rutgers University.

The License Agreement starts with co-development of Liposomal Cisplatin and Liposomal Carboplatin and their use in inhalation chemotherapies

EXCLUSIVE MANUFACTURING AGREEMENT WITH FORDOZ PHARMA FOR LIPOSOMAL ONCOLOGY DRUGS

Lipotech has signed Exclusive Manufacturing Agreement with ForDoz Pharma through know how it is bringing to the pilot manufacturing facility of ForDoz Pharma, with GMP certificates located in New Jersey

The manufacturing agreement will provide Liposomal Cisplatin and other Liposomal Oncology Drugs to be used for clinical trials

NASSOS ALEVIZOPOULOS (PhD) HAS JOINED OUR MANAGEMENT AS SCIENTIFIC BOARD MEMBER 

The manufacturing Nassos Alevizopoulos (PhD) has joined our Management as Scientific Board Member where he will act as the leading personality coordinating scientific and regulatory affairs of Lipotech Inc. for the path that goes for Orphan Drug Designation from FDA or EMA